Structure

Physi-Chem Properties

Molecular Weight:  386.14
Volume:  386.543
LogP:  2.719
LogD:  2.425
LogS:  -3.462
# Rotatable Bonds:  4
TPSA:  113.29
# H-Bond Aceptor:  7
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.684
Synthetic Accessibility Score:  4.344
Fsp3:  0.333
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.925
MDCK Permeability:  1.8037644622381777e-05
Pgp-inhibitor:  0.006
Pgp-substrate:  0.044
Human Intestinal Absorption (HIA):  0.019
20% Bioavailability (F20%):  0.782
30% Bioavailability (F30%):  0.24

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.022
Plasma Protein Binding (PPB):  94.97071075439453%
Volume Distribution (VD):  0.846
Pgp-substrate:  3.1816482543945312%

ADMET: Metabolism

CYP1A2-inhibitor:  0.968
CYP1A2-substrate:  0.509
CYP2C19-inhibitor:  0.596
CYP2C19-substrate:  0.067
CYP2C9-inhibitor:  0.739
CYP2C9-substrate:  0.876
CYP2D6-inhibitor:  0.953
CYP2D6-substrate:  0.324
CYP3A4-inhibitor:  0.839
CYP3A4-substrate:  0.209

ADMET: Excretion

Clearance (CL):  5.225
Half-life (T1/2):  0.843

ADMET: Toxicity

hERG Blockers:  0.01
Human Hepatotoxicity (H-HT):  0.402
Drug-inuced Liver Injury (DILI):  0.942
AMES Toxicity:  0.278
Rat Oral Acute Toxicity:  0.397
Maximum Recommended Daily Dose:  0.964
Skin Sensitization:  0.948
Carcinogencity:  0.866
Eye Corrosion:  0.003
Eye Irritation:  0.878
Respiratory Toxicity:  0.25

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC115249

Natural Product ID:  NPC115249
Common Name*:   Comazaphilone D
IUPAC Name:   [(6R,7R)-7-hydroxy-7-methyl-8-oxo-3-[(E)-prop-1-enyl]-5,6-dihydro-1H-isochromen-6-yl] 2,4-dihydroxy-6-methylbenzoate
Synonyms:   Comazaphilone D
Standard InCHIKey:  GIROBNCADSJPIJ-OQBWYENPSA-N
Standard InCHI:  InChI=1S/C21H22O7/c1-4-5-14-7-12-8-17(21(3,26)19(24)15(12)10-27-14)28-20(25)18-11(2)6-13(22)9-16(18)23/h4-7,9,17,22-23,26H,8,10H2,1-3H3/b5-4+/t17-,21-/m1/s1
SMILES:  C/C=C/C1=CC2=C(CO1)C(=O)[C@@](C)([C@@H](C2)OC(=O)c1c(C)cc(cc1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1689198
PubChem CID:   51041753
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0003477] Azaphilones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33529 Penicillium commune QSD-17 Species Aspergillaceae Eukaryota marine sediment southern China Sea n.a. PMID[21226488]
NPO19186 Penicillium commune Species Aspergillaceae Eukaryota n.a. mycelium n.a. PMID[21226488]
NPO19186 Penicillium commune Species Aspergillaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1312 Cell Line SW1990 Homo sapiens IC50 = 51000.0 nM PMID[575739]
NPT1209 Organism Pseudomonas fluorescens Pseudomonas fluorescens MIC = 16.0 ug.mL-1 PMID[575739]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 32.0 ug.mL-1 PMID[575739]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC > 256.0 ug.mL-1 PMID[575739]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC > 256.0 ug.mL-1 PMID[575739]
NPT20 Organism Candida albicans Candida albicans MIC > 256.0 ug.mL-1 PMID[575739]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC115249 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9932 High Similarity NPC137301
0.9863 High Similarity NPC76041
0.9863 High Similarity NPC184284
0.9862 High Similarity NPC472891
0.9732 High Similarity NPC472889
0.973 High Similarity NPC472890
0.973 High Similarity NPC69043
0.973 High Similarity NPC208173
0.973 High Similarity NPC478230
0.973 High Similarity NPC170189
0.9728 High Similarity NPC478224
0.9662 High Similarity NPC478231
0.96 High Similarity NPC478225
0.96 High Similarity NPC246466
0.9597 High Similarity NPC478221
0.9597 High Similarity NPC317585
0.947 High Similarity NPC478226
0.9392 High Similarity NPC84142
0.9355 High Similarity NPC191930
0.9329 High Similarity NPC164762
0.929 High Similarity NPC249181
0.9286 High Similarity NPC317544
0.9267 High Similarity NPC91809
0.9236 High Similarity NPC283041
0.9172 High Similarity NPC20237
0.915 High Similarity NPC472050
0.9145 High Similarity NPC471695
0.9128 High Similarity NPC210320
0.911 High Similarity NPC158634
0.9067 High Similarity NPC215711
0.9067 High Similarity NPC73411
0.9041 High Similarity NPC158472
0.9038 High Similarity NPC117985
0.9034 High Similarity NPC33144
0.9034 High Similarity NPC478200
0.9032 High Similarity NPC470339
0.9007 High Similarity NPC270160
0.9007 High Similarity NPC237440
0.8986 High Similarity NPC478202
0.898 High Similarity NPC244923
0.8974 High Similarity NPC472055
0.8973 High Similarity NPC32360
0.8973 High Similarity NPC247409
0.8973 High Similarity NPC268052
0.8947 High Similarity NPC56204
0.8938 High Similarity NPC328321
0.8933 High Similarity NPC473023
0.8926 High Similarity NPC86373
0.8926 High Similarity NPC280404
0.8926 High Similarity NPC42540
0.8926 High Similarity NPC210425
0.8926 High Similarity NPC277426
0.8926 High Similarity NPC151607
0.8919 High Similarity NPC82913
0.8904 High Similarity NPC191835
0.8889 High Similarity NPC70016
0.8889 High Similarity NPC215921
0.8882 High Similarity NPC4423
0.8882 High Similarity NPC77325
0.8867 High Similarity NPC83272
0.8859 High Similarity NPC159721
0.8851 High Similarity NPC472035
0.8851 High Similarity NPC313123
0.8851 High Similarity NPC478217
0.8851 High Similarity NPC53649
0.8851 High Similarity NPC478201
0.8851 High Similarity NPC472603
0.8844 High Similarity NPC52358
0.8839 High Similarity NPC471456
0.8839 High Similarity NPC99381
0.8836 High Similarity NPC70380
0.8831 High Similarity NPC470340
0.8816 High Similarity NPC94781
0.88 High Similarity NPC478203
0.88 High Similarity NPC126882
0.88 High Similarity NPC210966
0.88 High Similarity NPC103910
0.8792 High Similarity NPC474385
0.8792 High Similarity NPC322112
0.8784 High Similarity NPC472600
0.8784 High Similarity NPC156872
0.8784 High Similarity NPC472601
0.8776 High Similarity NPC94248
0.8776 High Similarity NPC212693
0.8776 High Similarity NPC472602
0.8774 High Similarity NPC155686
0.8774 High Similarity NPC192189
0.8767 High Similarity NPC235115
0.8766 High Similarity NPC46882
0.8766 High Similarity NPC205918
0.8766 High Similarity NPC200773
0.8766 High Similarity NPC240768
0.8766 High Similarity NPC132990
0.8759 High Similarity NPC175943
0.8758 High Similarity NPC44378
0.8758 High Similarity NPC473094
0.8758 High Similarity NPC280753
0.875 High Similarity NPC166583
0.875 High Similarity NPC53362
0.875 High Similarity NPC472036
0.8742 High Similarity NPC257558
0.8742 High Similarity NPC472034
0.8733 High Similarity NPC51106
0.8733 High Similarity NPC472006
0.8733 High Similarity NPC471731
0.8725 High Similarity NPC472605
0.8725 High Similarity NPC1704
0.8725 High Similarity NPC472604
0.8725 High Similarity NPC475730
0.8725 High Similarity NPC67650
0.8716 High Similarity NPC92655
0.871 High Similarity NPC470338
0.871 High Similarity NPC256141
0.871 High Similarity NPC167903
0.871 High Similarity NPC268992
0.871 High Similarity NPC113608
0.871 High Similarity NPC51824
0.871 High Similarity NPC470337
0.8707 High Similarity NPC71256
0.8704 High Similarity NPC473095
0.8704 High Similarity NPC473096
0.8701 High Similarity NPC158866
0.8701 High Similarity NPC180351
0.8701 High Similarity NPC469619
0.8701 High Similarity NPC469670
0.8701 High Similarity NPC179178
0.8693 High Similarity NPC37139
0.8693 High Similarity NPC240253
0.8693 High Similarity NPC471642
0.8693 High Similarity NPC240622
0.8693 High Similarity NPC471641
0.869 High Similarity NPC153783
0.8684 High Similarity NPC260946
0.8684 High Similarity NPC107625
0.8684 High Similarity NPC472033
0.8675 High Similarity NPC257025
0.8675 High Similarity NPC475201
0.8667 High Similarity NPC471733
0.8662 High Similarity NPC227062
0.8662 High Similarity NPC478027
0.8658 High Similarity NPC155205
0.8654 High Similarity NPC472799
0.8649 High Similarity NPC126739
0.8649 High Similarity NPC9121
0.8649 High Similarity NPC177307
0.8649 High Similarity NPC197666
0.8639 High Similarity NPC50455
0.8636 High Similarity NPC120171
0.8634 High Similarity NPC472049
0.8627 High Similarity NPC259632
0.8627 High Similarity NPC476463
0.8627 High Similarity NPC81835
0.8618 High Similarity NPC312789
0.8616 High Similarity NPC243701
0.8616 High Similarity NPC470810
0.8609 High Similarity NPC21873
0.8609 High Similarity NPC469542
0.8609 High Similarity NPC472610
0.8609 High Similarity NPC354984
0.8608 High Similarity NPC473395
0.86 High Similarity NPC130485
0.8599 High Similarity NPC16082
0.8599 High Similarity NPC304207
0.8599 High Similarity NPC79998
0.8599 High Similarity NPC56786
0.8599 High Similarity NPC476169
0.8599 High Similarity NPC80534
0.8599 High Similarity NPC68727
0.8599 High Similarity NPC259710
0.8599 High Similarity NPC217706
0.8599 High Similarity NPC48579
0.8599 High Similarity NPC207809
0.8599 High Similarity NPC82592
0.8599 High Similarity NPC473241
0.8599 High Similarity NPC108937
0.8599 High Similarity NPC279218
0.8598 High Similarity NPC472620
0.8591 High Similarity NPC105456
0.8591 High Similarity NPC295339
0.8591 High Similarity NPC139634
0.8591 High Similarity NPC88269
0.859 High Similarity NPC271681
0.859 High Similarity NPC210597
0.859 High Similarity NPC180944
0.8589 High Similarity NPC472619
0.8581 High Similarity NPC295036
0.8581 High Similarity NPC194579
0.8581 High Similarity NPC178467
0.8581 High Similarity NPC65837
0.8581 High Similarity NPC474771
0.8581 High Similarity NPC135837
0.8581 High Similarity NPC150928
0.8581 High Similarity NPC149372
0.8581 High Similarity NPC474849
0.858 High Similarity NPC43319
0.858 High Similarity NPC165460
0.8571 High Similarity NPC27407
0.8571 High Similarity NPC186686
0.8562 High Similarity NPC225173
0.8562 High Similarity NPC202112

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC115249 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8591 High Similarity NPD970 Clinical (unspecified phase)
0.8491 Intermediate Similarity NPD7075 Discontinued
0.8481 Intermediate Similarity NPD3817 Phase 2
0.8418 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8377 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8377 Intermediate Similarity NPD2532 Approved
0.8377 Intermediate Similarity NPD2533 Approved
0.8377 Intermediate Similarity NPD2534 Approved
0.8354 Intermediate Similarity NPD6801 Discontinued
0.8344 Intermediate Similarity NPD4380 Phase 2
0.8312 Intermediate Similarity NPD6799 Approved
0.8302 Intermediate Similarity NPD7819 Suspended
0.8302 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8282 Intermediate Similarity NPD6232 Discontinued
0.8242 Intermediate Similarity NPD7473 Discontinued
0.8239 Intermediate Similarity NPD1934 Approved
0.8228 Intermediate Similarity NPD6599 Discontinued
0.8205 Intermediate Similarity NPD1512 Approved
0.8187 Intermediate Similarity NPD2801 Approved
0.8137 Intermediate Similarity NPD5402 Approved
0.8086 Intermediate Similarity NPD3882 Suspended
0.8077 Intermediate Similarity NPD1511 Approved
0.8072 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD6166 Phase 2
0.8059 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD6797 Phase 2
0.8038 Intermediate Similarity NPD5403 Approved
0.8037 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8036 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8026 Intermediate Similarity NPD1510 Phase 2
0.8 Intermediate Similarity NPD6959 Discontinued
0.8 Intermediate Similarity NPD7251 Discontinued
0.8 Intermediate Similarity NPD3750 Approved
0.8 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7977 Intermediate Similarity NPD8150 Discontinued
0.7953 Intermediate Similarity NPD7808 Phase 3
0.7947 Intermediate Similarity NPD230 Phase 1
0.7929 Intermediate Similarity NPD7054 Approved
0.7929 Intermediate Similarity NPD5844 Phase 1
0.7922 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7922 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7911 Intermediate Similarity NPD5401 Approved
0.7908 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD7472 Approved
0.7871 Intermediate Similarity NPD1549 Phase 2
0.787 Intermediate Similarity NPD3818 Discontinued
0.7866 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD2796 Approved
0.784 Intermediate Similarity NPD7411 Suspended
0.7805 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7792 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD6559 Discontinued
0.7778 Intermediate Similarity NPD7074 Phase 3
0.7778 Intermediate Similarity NPD1607 Approved
0.7771 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7763 Intermediate Similarity NPD1240 Approved
0.7742 Intermediate Similarity NPD2935 Discontinued
0.7738 Intermediate Similarity NPD5711 Approved
0.7738 Intermediate Similarity NPD5710 Approved
0.7736 Intermediate Similarity NPD7390 Discontinued
0.7722 Intermediate Similarity NPD6190 Approved
0.7711 Intermediate Similarity NPD3749 Approved
0.7677 Intermediate Similarity NPD3748 Approved
0.7665 Intermediate Similarity NPD919 Approved
0.7661 Intermediate Similarity NPD3751 Discontinued
0.7658 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD4628 Phase 3
0.7651 Intermediate Similarity NPD7768 Phase 2
0.7647 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD1551 Phase 2
0.7619 Intermediate Similarity NPD5494 Approved
0.7607 Intermediate Similarity NPD3226 Approved
0.7595 Intermediate Similarity NPD2800 Approved
0.7584 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD8434 Phase 2
0.7568 Intermediate Similarity NPD7435 Discontinued
0.756 Intermediate Similarity NPD6234 Discontinued
0.7532 Intermediate Similarity NPD943 Approved
0.753 Intermediate Similarity NPD1465 Phase 2
0.7529 Intermediate Similarity NPD3787 Discontinued
0.7516 Intermediate Similarity NPD5406 Approved
0.7516 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD5408 Approved
0.7516 Intermediate Similarity NPD5404 Approved
0.7516 Intermediate Similarity NPD5405 Approved
0.7514 Intermediate Similarity NPD6535 Approved
0.7514 Intermediate Similarity NPD6534 Approved
0.7514 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6781 Approved
0.75 Intermediate Similarity NPD6777 Approved
0.75 Intermediate Similarity NPD6776 Approved
0.75 Intermediate Similarity NPD6780 Approved
0.75 Intermediate Similarity NPD6778 Approved
0.75 Intermediate Similarity NPD6779 Approved
0.75 Intermediate Similarity NPD6782 Approved
0.7485 Intermediate Similarity NPD920 Approved
0.7484 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD37 Approved
0.7468 Intermediate Similarity NPD2346 Discontinued
0.7466 Intermediate Similarity NPD9545 Approved
0.7453 Intermediate Similarity NPD3300 Phase 2
0.744 Intermediate Similarity NPD4965 Approved
0.744 Intermediate Similarity NPD4966 Approved
0.744 Intermediate Similarity NPD4967 Phase 2
0.7436 Intermediate Similarity NPD6651 Approved
0.7433 Intermediate Similarity NPD8319 Approved
0.7433 Intermediate Similarity NPD8320 Phase 1
0.7405 Intermediate Similarity NPD6099 Approved
0.7405 Intermediate Similarity NPD6100 Approved
0.7403 Intermediate Similarity NPD3764 Approved
0.7401 Intermediate Similarity NPD8312 Approved
0.7401 Intermediate Similarity NPD8313 Approved
0.7391 Intermediate Similarity NPD7700 Phase 2
0.7391 Intermediate Similarity NPD7699 Phase 2
0.7384 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7383 Intermediate Similarity NPD1201 Approved
0.7375 Intermediate Similarity NPD1243 Approved
0.7368 Intermediate Similarity NPD1247 Approved
0.7362 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD7874 Approved
0.7329 Intermediate Similarity NPD9493 Approved
0.7308 Intermediate Similarity NPD4060 Phase 1
0.7303 Intermediate Similarity NPD1470 Approved
0.7287 Intermediate Similarity NPD7698 Approved
0.7287 Intermediate Similarity NPD7696 Phase 3
0.7287 Intermediate Similarity NPD7697 Approved
0.7277 Intermediate Similarity NPD8151 Discontinued
0.7273 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD7199 Phase 2
0.7261 Intermediate Similarity NPD447 Suspended
0.7257 Intermediate Similarity NPD7228 Approved
0.7249 Intermediate Similarity NPD7870 Phase 2
0.7249 Intermediate Similarity NPD7871 Phase 2
0.7233 Intermediate Similarity NPD2799 Discontinued
0.7233 Intermediate Similarity NPD7033 Discontinued
0.7232 Intermediate Similarity NPD5953 Discontinued
0.7225 Intermediate Similarity NPD7701 Phase 2
0.7222 Intermediate Similarity NPD8166 Discontinued
0.7219 Intermediate Similarity NPD9269 Phase 2
0.7216 Intermediate Similarity NPD7286 Phase 2
0.7186 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7458 Discontinued
0.7184 Intermediate Similarity NPD3926 Phase 2
0.7179 Intermediate Similarity NPD6798 Discontinued
0.7179 Intermediate Similarity NPD2313 Discontinued
0.716 Intermediate Similarity NPD1652 Phase 2
0.7152 Intermediate Similarity NPD5124 Phase 1
0.7152 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD6355 Discontinued
0.7152 Intermediate Similarity NPD422 Phase 1
0.7151 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD7236 Approved
0.7134 Intermediate Similarity NPD6233 Phase 2
0.7126 Intermediate Similarity NPD1653 Approved
0.7126 Intermediate Similarity NPD7229 Phase 3
0.7113 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD7783 Phase 2
0.7113 Intermediate Similarity NPD7801 Approved
0.7105 Intermediate Similarity NPD9717 Approved
0.7095 Intermediate Similarity NPD7685 Pre-registration
0.7095 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD1203 Approved
0.7076 Intermediate Similarity NPD4288 Approved
0.707 Intermediate Similarity NPD3268 Approved
0.707 Intermediate Similarity NPD411 Approved
0.7067 Intermediate Similarity NPD9268 Approved
0.7053 Intermediate Similarity NPD6823 Phase 2
0.7052 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD6832 Phase 2
0.7045 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD2403 Approved
0.7044 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD5762 Approved
0.7037 Intermediate Similarity NPD5763 Approved
0.7032 Intermediate Similarity NPD2798 Approved
0.7031 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD4626 Approved
0.7019 Intermediate Similarity NPD4308 Phase 3
0.7012 Intermediate Similarity NPD7003 Approved
0.7006 Intermediate Similarity NPD6273 Approved
0.7006 Intermediate Similarity NPD3027 Phase 3
0.7006 Intermediate Similarity NPD4625 Phase 3
0.7 Intermediate Similarity NPD8368 Discontinued
0.6989 Remote Similarity NPD6212 Phase 3
0.6989 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6989 Remote Similarity NPD6213 Phase 3
0.6981 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6981 Remote Similarity NPD1613 Approved
0.6977 Remote Similarity NPD5353 Approved
0.6975 Remote Similarity NPD2438 Suspended
0.6968 Remote Similarity NPD2797 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data